share_log

Charles River Introduces Its Vector Tech Transfer Program To Safeguard Gene Therapy Development

Benzinga ·  May 30 20:02

Fast Track and Modular frameworks facilitate product development continuity via seamless process transfer to the Company's viral vector Center of Excellence

Charles River Laboratories International, Inc. (NYSE:CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks. Based on decades of viral vector contract development and manufacturing organization (CDMO) experience, the Company has designed a methodical program to drive successful, accelerated process transfer to its Maryland-based viral vector center of excellence (CoE) in as little as nine months.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment